Data from various retinal clinical trials suggest that there is a difference in efficacy in anti-VEGF therapies for patients with lower vision, according to a speaker here. During a presentation at ...
The treatment showed stability or improvement in the Diabetic Retinopathy Severity Scale (DRSS) and generally the drug was well tolerated.
In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...
Cafemutual is a complete guide on mutual fund business giving you all the mutual fund news, mutual fund analysis in India. At Cafemutual you will get mutual fund news with a focus on mutual fund ...
About AXPAXLI AXPAXLIâ„¢ (axitinib intravitreal injection, also known as OTX-TKI) is an investigational, bioresorbable, hydrogel incorporating axitinib, a small molecule, multi-target, tyrosine kinase ...
Eligible subjects who achieve best corrected visual acuity (BCVA) of 20/20 at Day 1 or gain at least 10 early treatment diabetic retinopathy (ETDRS) letters at Day 1 are then randomized to receive a ...
Over 537 million people globally suffer from diabetes, with 227 million in Asia Pacific. More than half may develop diabetic retinopathy (DR) within 10 years, potentially leading to blindness.
However, if your hair never seems to look its best, it might be worth getting to the root of the problem – and chances are, it starts at your scalp. “Scalp health definitely impacts hair ...
Each type of diabetes has unique symptoms, causes, and treatments. Learn more about how these types differ from one another. Prediabetes is the term that’s used when your blood sugar is higher ...
Diabetic retinopathy is a serious concern for people dealing with diabetes. Detecting diabetic retinopathy poses significant challenges, requiring skilled professionals, extensive manual image ...